Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprisi… Read more
Nath Bio-Genes (India) Limited (NATHBIOGEN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.160x
Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-1.09 Billion) by net assets (₹6.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nath Bio-Genes (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alma Metals Ltd
AU:ALM
|
0.228x |
|
Transuite.Org Inc.
OTCQB:TRSO
|
0.005x |
|
Energisme
PA:ALNRG
|
1.609x |
|
TWZ Corporation Public Company Limited
BK:TWZ
|
0.041x |
|
FIINU LS -10
F:LWW
|
N/A |
|
Setco Automotive Limited
NSE:SETCO
|
-0.071x |
|
Canna Global Acquisition Corp
NYSE:CNGL
|
-0.413x |
|
OPPSTAR
KLSE:0275
|
0.029x |
Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹6.44 Billion | ₹175.81 Million | 0.027x | -72.93% |
| 2024-03-31 | ₹6.10 Billion | ₹614.80 Million | 0.101x | +50.59% |
| 2023-03-31 | ₹5.73 Billion | ₹383.67 Million | 0.067x | +112.82% |
| 2022-03-31 | ₹5.42 Billion | ₹170.46 Million | 0.031x | +1633.30% |
| 2021-03-31 | ₹6.13 Billion | ₹11.13 Million | 0.002x | -89.32% |
| 2020-03-31 | ₹5.58 Billion | ₹94.74 Million | 0.017x | +139.22% |
| 2019-03-31 | ₹5.08 Billion | ₹-219.89 Million | -0.043x | +56.74% |
| 2018-03-31 | ₹4.69 Billion | ₹-469.84 Million | -0.100x | -512.04% |
| 2017-03-31 | ₹1.38 Billion | ₹33.43 Million | 0.024x | +120.81% |
| 2016-03-31 | ₹1.21 Billion | ₹-141.68 Million | -0.117x | -285.23% |
| 2015-03-31 | ₹1.07 Billion | ₹67.55 Million | 0.063x | -65.69% |
| 2014-03-31 | ₹817.78 Million | ₹150.28 Million | 0.184x | -25.68% |
| 2013-03-31 | ₹574.74 Million | ₹142.11 Million | 0.247x | -- |